comparison of glp 1 receptor agonists GLP1 vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Effects of GLP-1 receptor agonists

Description

Rising Prevalence of Diabetes and Obesity The global prevalence of type 2 diabetes, including the in the U.S., is increasing, largely due to rising rates of obesity, aging populations, and sedentary lifestyles

"And then, we discuss whether or not we're going to use a medical intervention," Basilico said, noting that some patients don't want to do a medical intervention

In January 2026, the company announced a strategic initiative to expand its PharmaPatch microneedle patch platform into select therapeutic peptides

Into this already complex picture has entered a third M: Mounjaro Studies estimate that 1 in 3 women are now using mounjaro and other GLP-1 weight loss medications - such as Ozempic and Wegovy